Thank you for the beautiful clarity of this precise and unarguable summary of exactly where MSB is at present in meeting the repeated challenges from FDA.
With your explanation it now appears condensed down to one final, make or break challenge to finish "the final potency work to demonstrate the standardisation of the trial product and the inventory". We can all understand that, and now wait with reasonable confidence to see if SI and friends can deliver. It seems deliverable.
Ann: Mesoblast Type A Meeting with FDA, page-108
-
- There are more pages in this discussion • 467 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2482 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 27045 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |